See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.86▲ 1.40%
← BEN page
XStocksXray
Research report · 22 October 2026

Franklin Templeton Inc (BEN)

Financials · Asset Management & Custody Banks · US stock · price as of 22 Oct 2026

Key indicators

Price$31.52
52-week range$21.11 – $36.28
Market cap$16.3B
P/E (trailing)20.1×
Dividend yield4.2%
Revenue (last 12 months)$9.3B
Revenue growth (3y a year)2.0%
Price / book1.4×
Return on equity6.9%

Fair value

Fair value (average of valid models)$30.67 middle half of models $29 – $32
Versus priceFair−3% to fair value
P/E multiple$30.53
P/B multiple$27.62
P/S multiple$33.86
Model uncertaintyMedium

X-Ray Score

31/ 100 · Medium confidence · ahead of 3% of sector peers
Valuation24
Growth15
Profitability17
Financial health61
Dividends61

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

14.2419.8325.4231.0236.61Fair value $312021-102023-012024-042025-072026-10

Executive summary

Franklin Templeton is a global investment manager that runs mutual funds, exchange-traded funds and separately managed accounts across equities, fixed income, multi-asset strategies and alternative assets. It operates through several specialist investment teams under different names. Its clients include individual investors who reach it through financial advisers and platforms, as well as pension funds, insurers and other institutions. The firm also provides related services such as fund administration and distribution.

The firm earns its revenue mostly from fees charged as a share of the assets it manages, so its income moves with the size of its funds and with investor flows. Revenue was $9.3 billion over the last twelve months, up 2.0% a year across the last three years. The operating margin is 9.7%, and the business earns 6% on the capital invested in it.

StocksXray gives Franklin Templeton Inc an X-Ray Score of 31 out of 100 (medium confidence), ahead of 3% of the S&P 500 stocks in its sector. Its strongest lens is financial health (61) and its weakest is growth (15).

Our fair value (the average of the valid models) is $30.67 (range $29.07 to $32.19). At $31.52 the stock trades 3% above that value, so the label is "Fair" with medium model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
Franklin Templeton Inc (BEN)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2021FY2022FY2023FY2024FY2025Now
Price$23.17$17.52$20.97$18.08$22.04$31.52
Market cap$11.4B$8.6B$10.3B$9.2B$11.4B$16.3B
P/E6.5×6.9×12.2×21.3×24.2×20.1×
Price / book1.0×0.7×0.9×0.7×0.9×1.4×
Dividend yield4.83%6.62%5.72%6.86%5.81%4.19%

Fundamentals checklist ● 1 Good · ● 0 Average · ● 6 Bad · each check graded against the sector

Risk models

Piotroski F-Score8 of 9Good

Growth

EPS growth (3y)−28.9%Bad
Revenue growth (3y)2.0%Bad
Growth consistency80%Bad

Valuation

Fair value vs price1.0×Bad

Profitability

Return on invested capital6.0%Bad
Operating margin9.7%Bad
stocksxray.com · page 2
XStocksXray
Franklin Templeton Inc (BEN)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY21FY22FY23FY24FY25LTM
Revenue8,4268,2757,8498,4788,7719,324
Net income1,8311,292883465525813
Diluted EPS ($)3.572.531.720.850.911.57
Net margin21.7%15.6%11.2%5.5%6.0%8.7%
Balance sheetFY21FY22FY23FY24FY25LTM
Total assets24,16828,06130,12132,46532,36836,243
Cash4,6474,7834,4024,4093,5743,761
Total debt3,3993,3763,0532,7802,3622,402
Equity11,22311,47511,91712,50812,07811,738
Dividend per share ($)1.121.161.201.241.28–

Revenue and net income US$ billions: navy revenue, teal net income

FY21FY22FY23FY24FY25

Margins blue gross, teal operating, brown net

0%7%15%22%FY21FY22FY23FY24FY25

Latest quarters

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ($M)2,1112,0642,3442,3272,2952,358
Growth vs a year earlier−1.9%−2.8%+6.0%+3.4%+8.7%+14.3%
Net income ($M)15192118256268172
Diluted EPS ($)0.260.15–0.460.490.31
stocksxray.com · page 3
XStocksXray
Franklin Templeton Inc (BEN)

Peers in Asset Management & Custody Banks

CompanyX-Ray
BEN · Franklin Templeton Inc31
AMP · Ameriprise Financial Inc67
APO · Apollo Global Management,...60
BX · Blackstone Inc.53
STT · State Street Corp50

Market Compass outlook for Financials: Favourable (71/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week+0.4%
1 month−3.9%
3 months−1.7%
6 months+17.0%
1 year+46.4%
3 years+63.8%
5 years+31.6%

Technical summary

DailyBearish4 bullish · 4 neutral · 8 bearish
WeeklyNeutral6 bullish · 1 neutral · 5 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish
50-day / 200-day average$32.85 / $29.52
52-week low / high$21.11 / $36.28
Classic pivot, support and resistanceS2 30.77 · S1 31.15 · P – · R1 31.91 · R2 32.30

Recent dividends

Ex-dividend dateAmount per share
30 Sep 2026$0.3300
29 Jun 2026$0.3300
31 Mar 2026$0.3300
30 Dec 2025$0.3300
30 Sep 2025$0.3200
27 Jun 2025$0.3200
stocksxray.com · page 4
XStocksXray
Franklin Templeton Inc (BEN)

Strengths

  • Piotroski F-Score of 8 out of 9: most of the nine accounting health tests pass.
  • Has raised its dividend for 6 years in a row.

Risks and weak spots

  • EPS growth (3y) is weak against Financials peers (−28.9%).
  • Revenue growth (3y) is weak against Financials peers (2.0%).
  • Growth consistency is weak against Financials peers (80%).
  • Fair value vs price is weak against Financials peers (1.0×).
  • Return on invested capital is weak against Financials peers (6.0%).
  • Operating margin is weak against Financials peers (9.7%).

Latest SEC filings

DateFormItems
10 Aug 20268-K2.03,8.01,9.01
7 Aug 2026424B5
5 Aug 2026424B5
31 Jul 202610-Q
31 Jul 20268-K2.02,5.03,7.01,9.01
30 Jul 20268-K1.01,1.02,2.03,9.01
23 Jul 20268-K5.02,9.01
5 Jun 20268-K8.01,9.01

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value is the average of up to 15 valuation models, most of them anchored to the company's own multiples, so it stays near the price and should be read as a range, not a point. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 23 Oct 2026